Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ronellenfitsch, Michael Wilfried"'
Autor:
Monden, Daniel, Raimann, Florian Jürgen, Neef, Vanessa, Dubinski, Daniel, Geßler, Florian, Keil, Fee, Forster, Marie-Thérèse, Ronellenfitsch, Michael Wilfried, Harter, Patrick N., Freiman, Thomas M., Hattingen, Elke, Seifert, Volker, Senft, Christian, Baumgarten, Peter
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 1820, p 1820 (2021)
Journal of Clinical Medicine
Volume 10
Issue 9
Journal of Clinical Medicine
Volume 10
Issue 9
Along with increasing average life expectancy, the number of elderly meningioma patients has grown proportionally. Our aim was to evaluate whether these specific patients benefit from surgery and to investigate a previously published score for decisi
Autor:
Braun, Yannick, Filipski, Katharina, Bernatz, Simon, Baumgarten, Peter, Roller, Bastian, Zinke, Jenny, Zeiner, Pia S., Ilina, Elena, Senft, Christian, Ronellenfitsch, Michael Wilfried, Plate, Karl, Bähr, Oliver, Hattingen, Elke, Steinbach, Joachim Peter, Mittelbronn, Michel, Harter, Patrick Nikolaus
Aims: Changes in metabolism are known to contribute to tumour phenotypes. If and how metabolic alterations in brain tumours contribute to patient outcome is still poorly understood. Epigenetics impact metabolism and mitochondrial function. The aim of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______603::399a1bcb020eece2a96ce1cff5764926
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/63862
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/63862
Autor:
Urban, Hans, Maurer, Gabriele Dorothea, Luger, Anna-Luisa, Lorenz, Nadja I., Sauer, Benedikt, Stroh, Christopher, Trojan, Jörg, Mittelbronn, Michel, Steinbach, Joachim Peter, Harter, Patrick Nikolaus, Ronellenfitsch, Michael Wilfried
Simple Summary: Therapeutic antibodies are an integral part of treatment regimens for metastasized colorectal cancer. In KRAS wildtype tumors both bevacizumab and cetuximab are active. While bevacizumab has previously been shown to induce tumor hypox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______603::b7e6a41d2eebc2d7f24e6e61df792926
http://publikationen.ub.uni-frankfurt.de/files/56542/container.zip
http://publikationen.ub.uni-frankfurt.de/files/56542/container.zip
Autor:
Fechner, Anne, Hubert, Kristina, Jahnke, Kolja, Knake, Susanne, Konczalla, Jürgen, Menzler, Katja, Ronellenfitsch, Michael Wilfried, Rosenow, Felix, Strzelczyk, Adam
Objective: Novel treatments are needed to control treatment‐resistant status epilepticus (SE). We present a summary of clinical cases where oral topiramate (TPM) was used in refractory SE (RSE) and superrefractory SE (SRSE). Methods: A review of me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______603::563e142ff8fc85b301d82a1028f1fe7c
http://publikationen.ub.uni-frankfurt.de/files/56312/epi.16382.pdf
http://publikationen.ub.uni-frankfurt.de/files/56312/epi.16382.pdf
Autor:
Voss, Martin, Batarfi, AbdulAziz, Steidl, Eike, Wagner, Marlies, Forster, Marie-Thérèse, Steinbach, Joachim Peter, Rödel, Claus, Bojunga, Jörg, Ronellenfitsch, Michael Wilfried
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 8, Iss 10, p 1608 (2019)
Journal of Clinical Medicine, Vol 8, Iss 10, p 1608 (2019)
Cerebral radiation necrosis is a common complication of the radiotherapy of brain tumours that can cause significant mortality. Corticosteroids are the standard of care, but their efficacy is limited and the consequences of long-term steroid therapy
The quest for new and improved therapies for glioblastoma (GB) has been mostly unsuccessful in more than a decade despite significant efforts. The few exceptions include the optimization of classical alkylating chemotherapy by including lomustine in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______603::17b5b765fb0af0427082ce6644b60ec3
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/50761
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/50761
Autor:
Foltyn, Martha, Luger, Anna-Luisa, Lorenz, Nadja I., Sauer, Benedikt, Mittelbronn, Michel Guy André, Harter, Patrick Nikolaus, Steinbach, Joachim Peter, Ronellenfitsch, Michael Wilfried
Background: Despite significant advances in the understanding of glioblastoma genetics and biology, survival is still poor. Hypoxia and nutrient depletion in the tumour microenvironment induce adaptive signalling and metabolic responses, which can in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______603::5d3d22436d0c60fdc1b2c2ec3ab0e2dc
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/52879
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/52879
Autor:
Ronellenfitsch, Michael Wilfried, Zeiner, Pia Susan, Mittelbronn, Michel Guy André, Urban, Hans, Pietsch, Torsten, Reuter, Dirk, Senft, Christian Alexander, Steinbach, Joachim Peter, Westphal, Manfred, Harter, Patrick Nikolaus
Glioblastoma (GB) is the most frequent primary brain tumor in adults with a dismal prognosis despite aggressive treatment including surgical resection, radiotherapy and chemotherapy with the alkylating agent temozolomide. Thus far, the successful imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______603::28a43722b2f7206ad9cf934e06d56c87
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/47150
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/47150
Autor:
Zeiner, Pia Susan, Zinke, Jenny, Kowalewski, Daniel Johannes, Bernatz, Simon, Tichy, Julia, Ronellenfitsch, Michael Wilfried, Thorsen, Frits, Berger, Annemarie, Forster, Marie-Thérèse, Muller, Arnaud, Steinbach, Joachim Peter, Beschorner, Rudi, Wischhusen, Jörg, Kvasnicka, Hans-Michael, Plate, Karl H., Stefanovic, Stefan, Weide, Benjamin, Mittelbronn, Michel Guy André, Harter, Patrick Nikolaus
Despite multidisciplinary local and systemic therapeutic approaches, the prognosis for most patients with brain metastases is still dismal. The role of adaptive and innate anti-tumor response including the Human Leukocyte Antigen (HLA) machinery of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______603::0b40b38b497223b5ca7d074e244c5d21
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/46495
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/46495
Autor:
Harter, Patrick Nikolaus, Jennewein, Lukas, Baumgarten, Peter, Ilina, Elena, Burger, Michael Christian, Thiepold, Anna-Luisa, Tichy, Julia Frederike, Zörnig, Martin, Senft, Christian Alexander, Steinbach, Joachim Peter, Mittelbronn, Michel Guy André, Ronellenfitsch, Michael Wilfried
Background: Current pathological diagnostics include the analysis of (epi-)genetic alterations as well as oncogenic pathways. Deregulated mammalian target of rapamycin complex 1 (mTORC1) signaling has been implicated in a variety of cancers including
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______603::e7efbe32732234ed243587349273af65
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/37992
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/37992